FDA will convene a one-day, in-person and virtual public workshop, “Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine ,” on Tuesday, Dec. 16, 2025 (1). The workshop is ...

Canadian Medical Association Journal article warns against relying on less effective treatments for anaphylaxis ...

U.S. net product revenue in third quarter of 2025 Continued U.S. product growth driven by direct-to-consumer (DTC) ...

Offers no-hassle, free virtual visit with healthcare provider for patients to receive neffy for $0 co-pay if eligible with ...

Ustekinumab had a market value of approximately $17.1 billion for the 12 months ending December 2024, per IQVIA.

$32.5 million in revenue, including $31.3 million in neffy U.S. net product revenue in third quarter of 2025 Continued U.S. product growth driven by direct-to-consumer (DTC) investments and real-world ...

ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office. "I was pretty shocked the first time I used it ...

Despite his best effort to check food labels, one college student details his close call with anaphylaxis and what he learned from it.

People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as to jab themselves in a thigh with an EpiPen, a new evidence review says. Adrenaline delivered with ...